 | • レポートコード：GIR-105X05518 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ドルテグラビルのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ドルテグラビルの種類別市場規模（10mg錠、50mg錠）、用途別市場規模（HIV感染防止、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ドルテグラビルの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：ViiV Healthcare (GSK)、Shanghai Desano Pharmaceuticals、Mylan、Aurobindo Pharma、LAURUS Labs、Adcock Ingram Limited ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：10mg錠、50mg錠 ・用途別分析2016年-2026年：HIV感染防止、その他 ・ドルテグラビルの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ドルテグラビルのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ドルテグラビルのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ドルテグラビルの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ドルテグラビルの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Dolutegravir market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Dolutegravir size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Dolutegravir market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Dolutegravir market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10mg Tablets
50mg Tablets
Market segment by Application can be divided into
Prevent HIV Infection Following Potential Exposure
Other
The key market players for global Dolutegravir market are listed below:
ViiV Healthcare (GSK)
Shanghai Desano Pharmaceuticals
Mylan
Aurobindo Pharma
LAURUS Labs
Adcock Ingram Limited
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Dolutegravir Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dolutegravir Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 10mg Tablets
1.2.3 50mg Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Dolutegravir Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Prevent HIV Infection Following Potential Exposure
1.3.3 Other
1.4 Global Dolutegravir Market Size & Forecast
1.4.1 Global Dolutegravir Sales in Value (2016-2026))
1.4.2 Global Dolutegravir Sales in Volume (2016-2026)
1.4.3 Global Dolutegravir Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Dolutegravir Production Capacity Analysis
1.5.1 Global Dolutegravir Total Production Capacity (2016-2026)
1.5.2 Global Dolutegravir Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dolutegravir Market Drivers
1.6.2 Dolutegravir Market Restraints
1.6.3 Dolutegravir Trends Analysis
2 Manufacturers Profiles
2.1 ViiV Healthcare (GSK)
2.1.1 ViiV Healthcare (GSK) Details
2.1.2 ViiV Healthcare (GSK) Major Business
2.1.3 ViiV Healthcare (GSK) Dolutegravir Product and Services
2.1.4 ViiV Healthcare (GSK) Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Shanghai Desano Pharmaceuticals
2.2.1 Shanghai Desano Pharmaceuticals Details
2.2.2 Shanghai Desano Pharmaceuticals Major Business
2.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Product and Services
2.2.4 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Dolutegravir Product and Services
2.3.4 Mylan Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Aurobindo Pharma
2.4.1 Aurobindo Pharma Details
2.4.2 Aurobindo Pharma Major Business
2.4.3 Aurobindo Pharma Dolutegravir Product and Services
2.4.4 Aurobindo Pharma Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 LAURUS Labs
2.5.1 LAURUS Labs Details
2.5.2 LAURUS Labs Major Business
2.5.3 LAURUS Labs Dolutegravir Product and Services
2.5.4 LAURUS Labs Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Adcock Ingram Limited
2.6.1 Adcock Ingram Limited Details
2.6.2 Adcock Ingram Limited Major Business
2.6.3 Adcock Ingram Limited Dolutegravir Product and Services
2.6.4 Adcock Ingram Limited Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Dolutegravir Sales by Manufacturer
3.1 Global Dolutegravir Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Dolutegravir Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Dolutegravir
3.4 Market Concentration Rate
3.4.1 Top 3 Dolutegravir Manufacturer Market Share
3.4.2 Top 6 Dolutegravir Manufacturer Market Share
3.5 Global Dolutegravir Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Dolutegravir Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dolutegravir Market Size by Region
4.1.1 Global Dolutegravir Sales in Volume by Region (2016-2026)
4.1.2 Global Dolutegravir Revenue by Region (2016-2026)
4.2 North America Dolutegravir Revenue (2016-2026)
4.3 Europe Dolutegravir Revenue (2016-2026)
4.4 Asia-Pacific Dolutegravir Revenue (2016-2026)
4.5 South America Dolutegravir Revenue (2016-2026)
4.6 Middle East and Africa Dolutegravir Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Dolutegravir Sales in Volume by Type (2016-2026)
5.2 Global Dolutegravir Revenue by Type (2016-2026)
5.3 Global Dolutegravir Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Dolutegravir Sales in Volume by Application (2016-2026)
6.2 Global Dolutegravir Revenue by Application (2016-2026)
6.3 Global Dolutegravir Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Dolutegravir Sales by Type (2016-2026)
7.2 North America Dolutegravir Sales by Application (2016-2026)
7.3 North America Dolutegravir Market Size by Country
7.3.1 North America Dolutegravir Sales in Volume by Country (2016-2026)
7.3.2 North America Dolutegravir Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Dolutegravir Sales by Type (2016-2026)
8.2 Europe Dolutegravir Sales by Application (2016-2026)
8.3 Europe Dolutegravir Market Size by Country
8.3.1 Europe Dolutegravir Sales in Volume by Country (2016-2026)
8.3.2 Europe Dolutegravir Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Dolutegravir Sales by Type (2016-2026)
9.2 Asia-Pacific Dolutegravir Sales by Application (2016-2026)
9.3 Asia-Pacific Dolutegravir Market Size by Region
9.3.1 Asia-Pacific Dolutegravir Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Dolutegravir Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Dolutegravir Sales by Type (2016-2026)
10.2 South America Dolutegravir Sales by Application (2016-2026)
10.3 South America Dolutegravir Market Size by Country
10.3.1 South America Dolutegravir Sales in Volume by Country (2016-2026)
10.3.2 South America Dolutegravir Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dolutegravir Sales by Type (2016-2026)
11.2 Middle East & Africa Dolutegravir Sales by Application (2016-2026)
11.3 Middle East & Africa Dolutegravir Market Size by Country
11.3.1 Middle East & Africa Dolutegravir Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Dolutegravir Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Dolutegravir Typical Distributors
12.3 Dolutegravir Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Dolutegravir Revenue by Type, (USD Million), 2021-2026
Table 2. Global Dolutegravir Revenue by Application, (USD Million), 2021-2026
Table 3. ViiV Healthcare (GSK) Basic Information, Manufacturing Base and Competitors
Table 4. ViiV Healthcare (GSK) Major Business
Table 5. ViiV Healthcare (GSK) Dolutegravir Product and Services
Table 6. ViiV Healthcare (GSK) Dolutegravir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Shanghai Desano Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Shanghai Desano Pharmaceuticals Major Business
Table 9. Shanghai Desano Pharmaceuticals Dolutegravir Product and Services
Table 10. Shanghai Desano Pharmaceuticals Dolutegravir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Dolutegravir Product and Services
Table 14. Mylan Dolutegravir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Aurobindo Pharma Major Business
Table 17. Aurobindo Pharma Dolutegravir Product and Services
Table 18. Aurobindo Pharma Dolutegravir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. LAURUS Labs Basic Information, Manufacturing Base and Competitors
Table 20. LAURUS Labs Major Business
Table 21. LAURUS Labs Dolutegravir Product and Services
Table 22. LAURUS Labs Dolutegravir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Adcock Ingram Limited Basic Information, Manufacturing Base and Competitors
Table 24. Adcock Ingram Limited Major Business
Table 25. Adcock Ingram Limited Dolutegravir Product and Services
Table 26. Adcock Ingram Limited Dolutegravir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Dolutegravir Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 28. Global Dolutegravir Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Dolutegravir, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Dolutegravir Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 31. Head Office and Dolutegravir Production Site of Key Manufacturer
Table 32. Global Dolutegravir Sales by Region (2016-2021e) & (K Pcs)
Table 33. Global Dolutegravir Sales by Region (2021-2026) & (K Pcs)
Table 34. Global Dolutegravir Revenue by Region (2016-2021e) & (USD Million)
Table 35. Global Dolutegravir Revenue by Region (2021-2026) & (USD Million)
Table 36. Global Dolutegravir Sales by Type (2016-2021e) & (K Pcs)
Table 37. Global Dolutegravir Sales by Type (2021-2026) & (K Pcs)
Table 38. Global Dolutegravir Revenue by Type (2016-2021e) & (USD Million)
Table 39. Global Dolutegravir Revenue by Type (2021-2026) & (USD Million)
Table 40. Global Dolutegravir Price by Type (2016-2021e) & (USD/Pcs)
Table 41. Global Dolutegravir Price by Type (2021-2026) & (USD/Pcs)
Table 42. Global Dolutegravir Sales by Application (2016-2021e) & (K Pcs)
Table 43. Global Dolutegravir Sales by Application (2021-2026) & (K Pcs)
Table 44. Global Dolutegravir Revenue by Application (2016-2021e) & (USD Million)
Table 45. Global Dolutegravir Revenue by Application (2021-2026) & (USD Million)
Table 46. Global Dolutegravir Price by Application (2016-2021e) & (USD/Pcs)
Table 47. Global Dolutegravir Price by Application (2021-2026) & (USD/Pcs)
Table 48. North America Dolutegravir Sales by Country (2016-2021e) & (K Pcs)
Table 49. North America Dolutegravir Sales by Country (2021-2026) & (K Pcs)
Table 50. North America Dolutegravir Revenue by Country (2016-2021e) & (USD Million)
Table 51. North America Dolutegravir Revenue by Country (2021-2026) & (USD Million)
Table 52. North America Dolutegravir Sales by Type (2016-2021e) & (K Pcs)
Table 53. North America Dolutegravir Sales by Type (2021-2026) & (K Pcs)
Table 54. North America Dolutegravir Sales by Application (2016-2021e) & (K Pcs)
Table 55. North America Dolutegravir Sales by Application (2021-2026) & (K Pcs)
Table 56. Europe Dolutegravir Sales by Country (2016-2021e) & (K Pcs)
Table 57. Europe Dolutegravir Sales by Country (2021-2026) & (K Pcs)
Table 58. Europe Dolutegravir Revenue by Country (2016-2021e) & (USD Million)
Table 59. Europe Dolutegravir Revenue by Country (2021-2026) & (USD Million)
Table 60. Europe Dolutegravir Sales by Type (2016-2021e) & (K Pcs)
Table 61. Europe Dolutegravir Sales by Type (2021-2026) & (K Pcs)
Table 62. Europe Dolutegravir Sales by Application (2016-2021e) & (K Pcs)
Table 63. Europe Dolutegravir Sales by Application (2021-2026) & (K Pcs)
Table 64. Asia-Pacific Dolutegravir Sales by Region (2016-2021e) & (K Pcs)
Table 65. Asia-Pacific Dolutegravir Sales by Region (2021-2026) & (K Pcs)
Table 66. Asia-Pacific Dolutegravir Revenue by Region (2016-2021e) & (USD Million)
Table 67. Asia-Pacific Dolutegravir Revenue by Region (2021-2026) & (USD Million)
Table 68. Asia-Pacific Dolutegravir Sales by Type (2016-2021e) & (K Pcs)
Table 69. Asia-Pacific Dolutegravir Sales by Type (2021-2026) & (K Pcs)
Table 70. Asia-Pacific Dolutegravir Sales by Application (2016-2021e) & (K Pcs)
Table 71. Asia-Pacific Dolutegravir Sales by Application (2021-2026) & (K Pcs)
Table 72. South America Dolutegravir Sales by Country (2016-2021e) & (K Pcs)
Table 73. South America Dolutegravir Sales by Country (2021-2026) & (K Pcs)
Table 74. South America Dolutegravir Revenue by Country (2016-2021e) & (USD Million)
Table 75. South America Dolutegravir Revenue by Country (2021-2026) & (USD Million)
Table 76. South America Dolutegravir Sales by Type (2016-2021e) & (K Pcs)
Table 77. South America Dolutegravir Sales by Type (2021-2026) & (K Pcs)
Table 78. South America Dolutegravir Sales by Application (2016-2021e) & (K Pcs)
Table 79. South America Dolutegravir Sales by Application (2021-2026) & (K Pcs)
Table 80. Middle East & Africa Dolutegravir Sales by Country (2016-2021e) & (K Pcs)
Table 81. Middle East & Africa Dolutegravir Sales by Country (2021-2026) & (K Pcs)
Table 82. Middle East & Africa Dolutegravir Revenue by Country (2016-2021e) & (USD Million)
Table 83. Middle East & Africa Dolutegravir Revenue by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa Dolutegravir Sales by Type (2016-2021e) & (K Pcs)
Table 85. Middle East & Africa Dolutegravir Sales by Type (2021-2026) & (K Pcs)
Table 86. Middle East & Africa Dolutegravir Sales by Application (2016-2021e) & (K Pcs)
Table 87. Middle East & Africa Dolutegravir Sales by Application (2021-2026) & (K Pcs)
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Dolutegravir Typical Distributors
Table 91. Dolutegravir Typical Customers
List of Figures
Figure 1. Dolutegravir Picture
Figure 2. Global Dolutegravir Sales Market Share by Type in 2020
Figure 3. 10mg Tablets
Figure 4. 50mg Tablets
Figure 5. Global Dolutegravir Sales Market Share by Application in 2020
Figure 6. Prevent HIV Infection Following Potential Exposure
Figure 7. Other
Figure 8. Global Dolutegravir Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 9. Global Dolutegravir Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Dolutegravir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Dolutegravir Sales (2016-2026) & (K Pcs)
Figure 30. Global Dolutegravir Production Capacity (2016-2026) & (K Pcs)
Figure 31. Global Dolutegravir Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Dolutegravir Market Drivers
Figure 33. Dolutegravir Market Restraints
Figure 34. Dolutegravir Market Trends
Figure 35. Global Dolutegravir Sales Market Share by Manufacturer in 2020
Figure 36. Global Dolutegravir Revenue Market Share by Manufacturer in 2020
Figure 37. Dolutegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Dolutegravir Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Dolutegravir Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Dolutegravir Sales Market Share by Region (2016-2026)
Figure 41. Global Dolutegravir Revenue Market Share by Region (2016-2026)
Figure 42. North America Dolutegravir Revenue (2016-2026) & (USD Million)
Figure 43. Europe Dolutegravir Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Dolutegravir Revenue (2016-2026) & (USD Million)
Figure 45. South America Dolutegravir Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Dolutegravir Revenue (2016-2026) & (USD Million)
Figure 47. Global Dolutegravir Sales Market Share by Type (2016-2026)
Figure 48. Global Dolutegravir Revenue Market Share by Type (2016-2026)
Figure 49. Global Dolutegravir Price by Type (2016-2026) & (USD/Pcs)
Figure 50. Global Dolutegravir Sales Market Share by Application (2016-2026)
Figure 51. Global Dolutegravir Revenue Market Share by Application (2016-2026)
Figure 52. Global Dolutegravir Price by Application (2016-2026) & (USD/Pcs)
Figure 53. North America Dolutegravir Sales Market Share by Country (2016-2026)
Figure 54. North America Dolutegravir Revenue Market Share by Country (2016-2026)
Figure 55. North America Dolutegravir Sales Market Share by Type (2016-2026)
Figure 56. North America Dolutegravir Sales Market Share by Application (2016-2026)
Figure 57. Europe Dolutegravir Sales Market Share by Country (2016-2026)
Figure 58. Europe Dolutegravir Revenue Market Share by Country (2016-2026)
Figure 59. Europe Dolutegravir Sales Market Share by Type (2016-2026)
Figure 60. Europe Dolutegravir Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Dolutegravir Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Dolutegravir Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Dolutegravir Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Dolutegravir Sales Market Share by Application (2016-2026)
Figure 65. South America Dolutegravir Sales Market Share by Country (2016-2026)
Figure 66. South America Dolutegravir Revenue Market Share by Country (2016-2026)
Figure 67. South America Dolutegravir Sales Market Share by Type (2016-2026)
Figure 68. South America Dolutegravir Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Dolutegravir Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Dolutegravir Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Dolutegravir Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Dolutegravir Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のドルテグラビル/リルピビリン併用薬市場 2021：企業別、地域別、種類・用途別 The Dolutegravir/Rilpivirine Combination Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 世界のドルテグラビルナトリウム市場 2021：企業別、地域別、種類・用途別 The Dolutegravir Sodium market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界のエルトロンボパグ錠市場 2021：企業別、地域別、種類・用途別 The Eltrombopag Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界のカベルゴリン錠市場 2021：企業別、地域別、種類・用途別 The Cabergoline Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- タブレットジェスチャー認識の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Gesture recognition is the ability of a device to identify and respond to different gestures, such as movement of hands, fingers, arms, head, or the entire body, of an individual. Scope of the Report: This report studies the Gesture Recognition for Tablets market status and outlook of Global and maj…